AMD Expands Taiwan Production Capacity as Global CPU Supply Constraints Intensify SK Hynix Joins Micron in the 1 Trillion Valuation Club Amid AI Memory Chip Frenzy Starbucks Turnaround Questioned After AI Initiative Stumbles Inside SpaceXs IPO Goldman Sachs and Morgan Stanley Lead Wall Streets Role in Potential RecordBreaking Listing UK Startup BioOrbit Sends DrugCrystallization Technology to Space for Cancer Treatment Development Aluminum Prices Surge Amid Geopolitical Tensions How Major US Companies Navigate Rising Costs Citi Q1 2026 Earnings EPS Surpasses Estimates by 133 Amid Improved Operational Efficiency Outset Medical Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher CTAS Q1 2026 Earnings EPS Misses Estimates Stock Sees Modest Gain ROG Q1 2026 Earnings EPS Beats Estimates by 10 Shares Edge Higher Cheche Group Q4 2024 Earnings Narrowed Loss Beats Estimates Despite Stock Decline Epsilon Energy Ltd EPSN Q1 2026 Earnings Modest EPS Amid Low Volumes Stock Slightly Lower Innovation Beverage Group IBG Slips 45 as Shares Test Critical Support Zone Pulse Biosciences PLSE Shows Modest Gain as Stock Holds Above Key Support Evolution Global Acquisition Corp EVOX Holds Steady at Trust Value Amid Merger Uncertainty Paylocity Holding PCTY Edges Higher as Shares Test Resistance Zone Montauk Renewables MNTK Gains 42 as Renewable Energy Stock Finds Support Near 153 Insight Molecular Diagnostics Inc IMDX Gains 575 as Momentum Builds Toward Key Resistance Insperity Inc NSP Surges 4 as Shares Test Key Resistance Zone Labcorp Holdings LH Consolidates Near 258 as Traders Eye Key Support and Resistance Levels Nuveen Select Maturities Municipal Fund Holds Steady at 935 Flat Trading Reflects Market Indecision Mtron Industries MPTI Edges Higher as Shares Approach Key Resistance near 84 Aramark ARMK Edges Higher as Support Holds Resistance in Sight USIran Talks Show Progress but Key Disagreements Persist on Uranium Enrichment and Strait of Hormuz Tolls FOLD Q4 2025 Earnings EPS Falls Short of Estimates Stock Unchanged Treace Medical Concepts TMCI Advances 397 as Stock Tests Key Resistance at 317